BBC vs. BIB

Last updated Jun 3, 2026

BBC (Virtus LifeSci Biotech Clinical Trials ETF) and BIB (ProShares Ultra Nasdaq Biotechnology) are both exchange-traded funds - BBC is a Health & Biotech Equities fund tracking the LifeSci Biotechnology Clinical Trials Index, while BIB is a Leveraged Equities fund tracking the NASDAQ Biotechnology Index (200%). Both are passively managed. Over the past 10 years, BBC returned 7.60%/yr vs 5.32%/yr for BIB. Their correlation of 0.85 suggests significant overlap in exposure. BBC charges 0.79%/yr vs 0.95%/yr for BIB.

Performance

BBC vs. BIB - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Virtus LifeSci Biotech Clinical Trials ETF (BBC) and ProShares Ultra Nasdaq Biotechnology (BIB). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, BBC achieves a 8.17% return, which is significantly higher than BIB's -3.86% return. Over the past 10 years, BBC has outperformed BIB with an annualized return of 7.60%, while BIB has yielded a comparatively lower 5.32% annualized return.

BBC

• 1D: -4.90%
• 1M: -4.81%
• YTD: 8.17%
• 6M: 20.12%
• 1Y: 123.11%
• 3Y*: 19.82%
• 5Y*: -2.05%
• 10Y*: 7.60%

BIB

• 1D: -5.85%
• 1M: -3.85%
• YTD: -3.86%
• 6M: -2.60%
• 1Y: 74.08%
• 3Y*: 13.19%
• 5Y*: -1.24%
• 10Y*: 5.32%

*Multi-year figures are annualized to reflect compound growth (CAGR)

BBC vs. BIB - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
BBC Virtus LifeSci Biotech Clinical Trials ETF	8.17%	63.77%	-1.11%	-1.80%	-35.13%	-22.31%	30.32%	63.81%	-18.29%	57.85%
BIB ProShares Ultra Nasdaq Biotechnology	-3.86%	59.21%	-9.84%	-1.06%	-28.85%	-6.02%	39.79%	46.71%	-24.93%	40.49%

Correlation

The correlation between BBC and BIB is 0.80, indicating a strong positive relationship between their price movements. Combining them offers limited diversification - they tend to fall together during downturns.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.80
Correlation (3Y) Calculated over the trailing 3-year period	0.82
Correlation (5Y) Calculated over the trailing 5-year period	0.84
Correlation (10Y) Calculated over the trailing 10-year period	0.84
Correlation (All Time) Calculated using the full available price history since Dec 18, 2014	0.85

The correlation between BBC and BIB has been stable across timeframes, ranging from 0.80 to 0.85 - a consistent structural relationship.

BBC vs. BIB - Sectors Allocation Comparison

Sectors	BBC	BIB
Healthcare	100.0%	63.8%
Basic Materials	-	-
Communication Services	-	-
Consumer Cyclical	-	-
Consumer Defensive	-	-
Energy	-	-
Financial Services	-	7.0%
Industrials	-	-
Real Estate	-	-
Technology	-	-
Utilities	-	-

Return for Risk

BBC vs. BIB — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BBC

BBC Risk / Return Rank: 90
BBC Sharpe Ratio Rank: 93
BBC Sortino Ratio Rank: 89
BBC Omega Ratio Rank: 79
BBC Calmar Ratio Rank: 96
BBC Martin Ratio Rank: 94

BIB

BIB Risk / Return Rank: 63
BIB Sharpe Ratio Rank: 54
BIB Sortino Ratio Rank: 51
BIB Omega Ratio Rank: 46
BIB Calmar Ratio Rank: 85
BIB Martin Ratio Rank: 77

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BBC vs. BIB - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Virtus LifeSci Biotech Clinical Trials ETF (BBC) and ProShares Ultra Nasdaq Biotechnology (BIB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	BBC	BIB	Difference
Sharpe ratio Return per unit of total volatility	3.49	1.89	+1.60
Sortino ratio Return per unit of downside risk	4.11	2.52	+1.60
Omega ratio Gain probability vs. loss probability	1.48	1.30	+0.18
Calmar ratio Return relative to maximum drawdown	8.82	4.72	+4.10
Martin ratio Return relative to average drawdown	28.55	15.18	+13.38
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

BBC vs. BIB - Sharpe Ratio Comparison

The current BBC Sharpe Ratio is 3.49, which is higher than the BIB Sharpe Ratio of 1.89. The chart below compares the historical Sharpe Ratios of BBC and BIB, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	BBC	BIB	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	3.49	1.89	+1.60
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.05	-0.03	-0.02
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.20	0.11	+0.09
Sharpe Ratio (All Time) Calculated using the full available price history	0.12	0.33	-0.21

Drawdowns

BBC vs. BIB - Drawdown Comparison

The maximum BBC drawdown since its inception was -76.85%, which is greater than BIB's maximum drawdown of -67.24%. Use the drawdown chart below to compare losses from any high point for BBC and BIB.

Drawdown Indicators

	BBC	BIB	Difference
Max Drawdown Largest peak-to-trough decline	-76.85%	-67.24%	-9.61%
Max Drawdown (1Y) Largest decline over 1 year	-15.10%	-16.92%	+1.82%
Max Drawdown (3Y) Largest decline over 3 years	-54.45%	-45.30%	-9.15%
Max Drawdown (5Y) Largest decline over 5 years	-72.44%	-65.86%	-6.58%
Max Drawdown (10Y) Largest decline over 10 years	-76.85%	-66.20%	-10.65%
Current Drawdown Current decline from peak	-30.57%	-29.32%	-1.25%
Average Drawdown Average peak-to-trough decline	-37.14%	-32.75%	-4.39%
Ulcer Index Depth and duration of drawdowns from previous peaks	4.66%	5.26%	-0.60%

Volatility

BBC vs. BIB - Volatility Comparison

The current volatility for Virtus LifeSci Biotech Clinical Trials ETF (BBC) is 11.21%, while ProShares Ultra Nasdaq Biotechnology (BIB) has a volatility of 13.90%. This indicates that BBC experiences smaller price fluctuations and is considered to be less risky than BIB based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	BBC	BIB	Difference
Volatility (1M) Calculated over the trailing 1-month period	11.21%	13.90%	-2.69%
Volatility (6M) Calculated over the trailing 6-month period	26.65%	30.72%	-4.07%
Volatility (1Y) Calculated over the trailing 1-year period	35.74%	39.58%	-3.84%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	39.31%	43.53%	-4.22%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	37.75%	46.50%	-8.75%

BBC vs. BIB - Expense Ratio Comparison

BBC has a 0.79% expense ratio, which is lower than BIB's 0.95% expense ratio.

Dividends

BBC vs. BIB - Dividend Comparison

BBC's dividend yield for the trailing twelve months is around 1.57%, more than BIB's 0.64% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
BBC Virtus LifeSci Biotech Clinical Trials ETF	1.57%	1.70%	1.00%	0.34%	0.00%	0.00%	0.00%	0.00%	0.00%	2.09%	0.00%	0.51%
BIB ProShares Ultra Nasdaq Biotechnology	0.64%	0.77%	1.69%	0.07%	0.03%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions

Can I hold both BBC and BIB in my portfolio?

BBC and BIB have a correlation of 0.80, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, BBC or BIB?

BIB has higher volatility (13.90%) compared to BBC (11.21%). In terms of maximum drawdown, BBC dropped -76.85% vs BIB's -67.24%.

Which ETF is better, BBC or BIB?

On 10-year performance, BBC leads with 7.60% vs 5.32% for BIB. On fees, BBC is cheaper at 0.79% per year. On volatility, BBC has been the lower-risk option at 11.21%. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF has performed better, BBC or BIB?

Over the 10-year period, BBC has performed better with a 7.60% return vs 5.32%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

Which ETF is cheaper, BBC or BIB?

BBC is cheaper with a 0.79% expense ratio, compared with 0.95% for BIB.

Which ETF pays a higher dividend yield, BBC or BIB?

BBC has the higher dividend yield at 1.57%, compared with 0.64% for BIB.

What is the main difference between BBC and BIB?

BBC is categorized as Health & Biotech Equities, while BIB is Leveraged Equities. BBC tracks LifeSci Biotechnology Clinical Trials Index, while BIB tracks NASDAQ Biotechnology Index (200%). They also come from different issuers: Virtus Investment Partners and ProShares. Their fees differ too: 0.79% for BBC and 0.95% for BIB.

Which has better risk-adjusted returns?

BBC currently has the higher Sharpe Ratio (3.49 vs 1.89), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.